Justices Want SG's Take On Enablement In Antibody IP Fight
The U.S. Supreme Court asked the solicitor general Monday to weigh in on Amgen's bid to undo a Federal Circuit decision tossing its jury win against Sanofi and Regeneron Pharmaceuticals Inc....To view the full article, register now.
Already a subscriber? Click here to view full article